Michael Trzupek served as Executive Vice President and Chief Financial Officer of Core Scientific from September 2020 until his resignation on April 4, 2022. He was engaged under a letter agreement providing for an annual base salary of $300,000 and received an initial equity grant of 2,000,000 RSUs in October 2020, with an additional 500,000 RSUs granted in July 2021.
The proxy statement contains no information regarding his prior employment history, education, or board affiliations.
Biography extracted from Core Scientific DEF 14A filed 2022-04-08 View cached copy (2026-09-13)Live source ↗
Roles
Contiguous filings for the same role are collapsed into a single tenure span. Click a row to see the underlying filings.
| Company | Role | Tenure | Filings |
|---|---|---|---|
| Core Scientific | Chief Financial Officer | 2022-01 → present (4y 10mo) | 1 |
Compensation
| Year | Role as filed | Salary | Stock awards | Total | Source |
|---|---|---|---|---|---|
| 2021 | EVP and Chief Financial Officer | $300.8K | $9.21M | $9.51M | View cached copy (2026-09-27)Live source ↗ |
| 2020 | EVP and Chief Financial Officer | $75.0K | $13.80M | $13.88M | View cached copy (2026-09-27)Live source ↗ |
As reported in the company's DEF 14A Summary Compensation Table (SEC Reg S-K Item 402(c)). Stock and option awards are grant-date fair values — what the award was worth on the day it was granted, not cash received and not what it is worth now. Every row here reconciles: its columns add up to the total the filing printed.